MétaCan
Menu
Back to cohort

Preventing CMV Viremia and Disease 3–6 Months After Renal Transplantation

2010· article· en· W2003519115 on OpenAlexaff
Atul Humar

Bibliographic record

VenueAmerican Journal of Transplantation · 2010
Typearticle
Languageen
FieldMedicine
TopicCytomegalovirus and herpesvirus research
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsMedicineViremiaDiseaseClinical trialTransplantationIntensive care medicineRandomized controlled trialViral loadPre-exposure prophylaxisInternal medicineImmunologyPediatricsVirusHuman immunodeficiency virus (HIV)Men who have sex with men

Abstract

fetched live from OpenAlex

To the Editor: The letter by Mossad et al. raises some important issues regarding strategies for preventing CMV disease occurring after completion of antiviral prophylaxis (i.e. late-onset CMV). It is correct that in the IMPACT trial, for patients receiving 100 days of prophylaxis, the majority of late-onset disease occurred between month 3 and month 6 posttransplant (1). I agree that routine virologic monitoring after completing 100 days of prophylaxis (a hybrid prophylaxis/pre-emptive strategy) may be an alternative prevention approach (vs prolongation of prophylaxis). However, based on the current literature it is unclear what the comparative efficacy of this would be for the prevention of late-onset disease. In one study analyzing the potential value of such a strategy after completing of a 3 month course of antiviral prophylaxis, routine viral load monitoring would have predicted late-onset disease in only 24/64 (38%) cases (2). Since in vivo viral doubling time may be quite rapid in high-risk transplant patients (in the range of 1–2 days) (3), it may be that more intensive viral load monitoring (e.g. weekly) would be required in order to prove effective in preventing disease. Such intensive monitoring may be logistically difficult in some settings once patients are beyond 3 months posttransplant. Ideally a randomized trial comparing prolonged prophylaxis versus a hybrid prophylaxis/pre-emptive approach would help better define the best method for prevention of late-onset disease. Alternatively the use of better predictive tools such as cell mediated immunity assessments, may allow a more individually tailored approach for prophylaxis in the future. More simple measurements of immune response such as seroconversion in donor-seropositive/recipient-seronegative patients (D+/R–) do not appear to have significant clinical utility for prediction of late-onset CMV disease (4). However, assessment of CMV-specific CD4+ or CD8+ T-cell responses may be more useful for predicting late-onset disease. For example, detection of CMV-specific CD4+ T cells was associated with protection from subsequent viremia in a cohort of kidney transplant recipients (5). However, more data is needed on the predictive value of such assessments before they can be adopted into routine clinical practice. The author of this manuscript has conflicts of interest to disclose as described by the American Journal of Transplantation. Atul Humar has received grant support and/or honoraria from Roche, Astellas, Pfizer and CSL Behring.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.007
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.287
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractno

Explore more

Same venueAmerican Journal of TransplantationSame topicCytomegalovirus and herpesvirus researchFrench-language works237,207